Farmax India Ltd


BSE: 590094 | NSE: FARMAXIND | ISIN: INE890I01035 
Market Cap: [Rs.Cr.] 20 | Face Value: [Rs.] 1
Industry: Food - Processing - Indian

 Discuss this stock

Board Meet

10-Feb-14 
Quarterly Results 
08-Nov-13 
Quarterly Results 
31-Aug-13 
Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 31, 2013, inter alia, to Authorize the Managing Director of the Company to file a legal case with regard to the GDR Issue. Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2013, has considered and approved the following: - To Authorize the Managing Director of the Company to file a legal case with regard to the GDR Issue. (As per BSE Announcement Dated on 31.08.2013) 
14-Aug-13 
Quarterly Results 
01-Aug-13 
Farmax India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 30, 2013, inter alia, to consider the following: 1. To consider the erosion of the Networth of the Company as per the Sick Industrial Companies Act, 1985. 2. To consider to make a reference to the Board for Industrial and Financial Reconstruction. Farmax India Ltd has informed BSE that the Board Meeting of the Company which was supposed to be held on July 30, 2013 is now postponed to August 01, 2013, inter alia, to consider the following: 1. To consider the erosion of the Networth of the Company as per the Sick Industrial Companies Act 1985. 2. To consider to make a reference to the Board for Industrial and Financial Reconstruction. (As per BSE Announcement Dated on 29.07.2013) (Revised) (As Per BSE Bulletin Dated on 30.07.2013) Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 01, 2013, inter alia, has considered and approved the following business: 1. To take note that the Company has become a Sick Company. 2. To make a reference to the Board for Industrial and Financial Reconstruction. (As per BSE Announcement Dated on 01.08.2013) 

AGM

29-Jul-13
Farmax India Ltd has informed BSE that the 18th Annual General Meeting (AGM) of the Company was held on July 29, 2013. 
29-Sep-12
Farmax India Ltd has informed BSE that the 17th Annual General Meeting (AGM) of the Company was held on September 29, 2012. 
28-Oct-11
AGM 28/10/2011 Farmax India Ltd has informed BSE that the members at the 16th Annual General Meeting (AGM) of the Company held on October 28, 2011, inter alia, have transacted the following: 1. Shareholders adopted the Directors' Report, the Audited Profit and Loss Account, the Balance Sheet and Cash Flow statement as at March 31, 2011. 2. Mr. A V Ramaraju who retired by rotation and being eligible, offered himself for re-appointment was re-appointed. 3. M/s. K Prahalda Rao & Co. are appointed as Statutory Auditors of the company to hold office from the conclusion of this Annual General Meeting until the conclusion of the next Annual General Meeting of the Company. 4. Appointment of Mr. Omkareshwar Ganganboina as a Director of the Company. (As Per BSE Announcement Website dated on 28.10.2011) 
09-Dec-10
AGM 09/12/2010 Farmax India Ltd has informed BSE that the following items of business have been considered and approved by the Shareholders in the 15th Annual General Meeting (AGM) of the Company held on December 09, 2010: 1. Approval of Audited Balance Sheet as at March 31, 2010 and Profit and Loss Account for the period ended as on that date, together with the report of the Board of Directors' and Auditor's thereon. 2. Appointment of Mrs. P. Hymavathi, who retires by rotation as Director. 3. Appointment of Mr. I. Srinivasa Raju, who retires by rotation as Director. 4. Re-appointment of M/s. K. Prahlada Rao & Co., Chartered Accountants as Statutory Auditors of the Company. 5. Alteration of Articles of Association. (As Per BSE Announcement Website dated on 10.12.2010) 

EGM

08-May-13
Farmax India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 08, 2013, has approved and considered the following : 1. To lease out the factory premises as per section 293 (1) (a) of the Companies Act, 1956. 2. Appointment of Bhaskara Rao & Associates as Statutory Auditors of the Company for the Financial Year 2012-13. 3. To hold Extra-Ordinary general Meeting on May 08, 2013 to take shareholders approval for item nos. 1 & 2 above. Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on May 08, 2013. (As per BSE Announcement Dated on 16.04.2013) Farmax India Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on May 08, 2013. (As Per BSE Announcement Dated on 08.05.2013) 
19-Dec-11
Farmax India Ltd has informed BSE hat a meeting of the Board of Directors of the Company will be held on February 17, 2012 to review the process or progress of Preferential Allotment initiated in terms of special resolution passed in the EGM held on December 19, 2011. 
01-Jan-10
Farmax Retail (India) Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 02, 2009, inter alia, has considered and approved the following: 1. Increase of Authorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. 4. Convening EGM of the shareholders on January 01, 2010 for the above matters. Farmax Retail (India) Ltd has informed BSE that an Extra Ordinary General Meeting (EGM) of the Company will be held on January 01, 2010.inter alia, to transact the following items of business: 1. Increase of Authorized Share Capital: - To increase the Authorized Share Capital of the Company from Rs. 14,00,00,000/- (Rupees Fourteen Crores Only) divided into 1,40,00,000 (One Crore Forty Lakhs) equity shares of Rs. 10/- (Rupees Ten Only) each to Rs. 50,00,00,000/- (Rupees Fifty Crores Only) divided into 5,00,00,000 (Five Crores) equity shares of Rs. 10/- (Rupees Ten Only) each, ranking pari passu with the existing equity shares & consequential amendment in the Memorandum of Association of the Company. 2. Sub-division of the Face Value of Equity Shares: - For sub-division of each of the existing issued equity shares of Rs. 10/- (Rupees Ten Only) each in the issued, subscribed and paid-up capital of the Company into 2 (Two) equity shares of the face value of Rs. 5/- (Rupees Five Only) each fully paid up consequential amendment in the Memorandum and Articles of Association pertaining to the Share Capital of the Company be accordingly altered. 3. To raise monies on preferential basis: - To offer, issue and allot (including with provisions for reservation on firm and / or competitive basis, of such part of issue and for such categories of persons including employees of the Company as may be permitted) either in India or in the course of international offering(s) in one or more foreign markers, such number of Equity Shares with or without a green shoe option. Global Depository Receipts (GDRs), in registered or bearer form, Foreign Currency Convertible Bonds (FCCBs), Qualified Institutional Placement (as defined by the SEBI (DIP) Guidelines, 2000) pursuant to a Qualified Institutions Placements, as provided under Chapter XIIIA of the SEBI DIP Guidelines (QIP) and / or securities with or without detachable warrants with right exercisable by the warrant holders to convert or subscribe to Equity Shares (all of which are hereinafter collectively referred to as Securities) or any combination of Securities, in one or more tranches, whether rupee denominated or denominated in foreign currency, to any eligible person, including foreign / resident invertors (whether institutions, incorporated bodies, mutual funds, individuals or otherwise), Foreign Institutional Investors, Indian and / or Multilateral Financial Institutions, Mutual Funds, Non-Resident Indians, stabilizing agents, and / or any other categories of investors, whether they be holders of shares of the Company or not (collectively called the Investors) through public issue(s) of prospectus in India or outside India, a qualified institutional placement, a rights offering, private placements(s) in India or outside India, or a combination thereof at such time or times, at such price or prices, at a discount or premium to market price or prices in such manner and on such terms and conditions as may be deemed appropriate by the Board at its absolute discretion including the discretion to determine the categories of Investors to whom the offer, issue and allotment shall be made to the exclusion of all other categories of Investors at the time of such offer, issue and allotment considering the prevailing market conditions and other relevant factors and wherever necessary in consultation with Lead Managers, up to an amount not exceeding Rs. 500 Crores (Rupees Five Hundred Crores Only) either in foreign currency or Indian Rupees inclusive of such premium as may be determined by the Board, in any convertible foreign currency, as the Board at its absolute discretion may deem fit and appropriate, subject to necessary provisions & approvals. (As Per BSE Announcement Dated on 30/12/2009) Farmax Retail (India) Ltd has informed BSE that the members at the Extra Ordinary General Meeting (EGM) of the Company held on January 01, 2010, inter alia, have approved the following: 1. Increase ofAuthorized Capital from Rs. 14 Crores to Rs. 50 Crores. 2. Sub-division of the face value of equity shares having the present value of Rs. 10/- each into 2 (two) equity shares of Rs. 5/- each. 3. Raising monies up to INR 500 Crores by issue of FCCBs/GDRs/FPO/QIPs in accordance with the provisions of all applicable laws. (As Per BSE Announcement Dated on 04/01/2010) 

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Hatsun AgroProd. 2,931.06 34.98 22.62 9.13 37.7 20.6 3.13
Zydus Wellness 2,064.46 18.42 8.05 15.24 43.8 44.7 0.00
KRBL 1,409.47 6.56 1.77 4.17 20.5 17.2 1.23
Esteem Bio Org. 929.52 364.33 36.48 25.31 15.0 13.5 0.12
Kwality 659.38 6.26 2.41 6.86 42.6 20.1 3.41
Heritage Foods 653.78 12.19 4.61 5.36 42.5 30.2 1.28
Eco Friendly 649.09 369.15 20.37 18.46 15.2 11.2 0.38
REI Agro 541.27 6.81 0.21 6.55 8.3 11.4 1.98
Avanti Feeds 533.04 11.89 4.45 2.69 28.0 29.0 0.50
Mount Everest 381.65 287.82 8.67 214.22 0.6 0.6 0.00
DFM Foods 329.75 43.33 9.83 9.69 19.8 19.1 2.18
L T Foods 295.33 9.19 1.20 6.71 14.7 11.7 3.67
Vikas Wsp 206.79 0.00 0.15 0.91 27.9 39.7 0.11
Lotte India 203.00 30.47 0.45 0.00 1.5 1.9 0.00
Lakshmi Energy 163.59 1.93 0.21 5.80 1.6 8.3 1.29

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

M Srinivasa Reddy , Chairman & Managing Director  

I Srinivasa Raju , Director  

A V Rama Raju , Director  

Omkareswar Ganganboina , Director  


Company Head Office / Quarters:
Survey No 658 Bowrampet Villag,
Qutubullapur Mandal,
Ranga Reddy,
Andhra Pradesh-501505
Phone :
Fax :
E-mail : cs@farmax.co.in
Web : http://www.farmax.co.in
Registrars:
Big Share Services Pvt Ltd
3rd Flr 306 Rightwin
Amrutha Ville
Somajiguda
Hyderabad-500082

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Apr-2014
M T W T F S S
14 15 16 17 18 19 20
IPO
listNo IPO today
Economic Events
list Italian Industrial Orders s.a. (MoM)
list Italian Industrial Orders n.s.a. (YoY)
Results
list Reliance Inds.